Finadium thinks that the demand for collateral for OTC derivatives trades, particularly on CCPs, will create a mini-boom in the US as insurance companies and corporations scramble for treasuries and cash. Does the industry agree?
Finadium thinks that the demand for collateral for OTC derivatives trades, particularly on CCPs, will create a mini-boom in the US as insurance companies and corporations scramble for treasuries and cash. Does the industry agree?